SuperworthTempest Therapeutics shares outstanding TPST
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 15.2M
- On a year earlier
- +300.3%
- more shares
Tempest Therapeutics had 15.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 300.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 4.9M | +56% |
| FY2024 | 3.1M | +110% |
| FY2023 | 1.5M | +42% |
| FY2022 | 1.1M | +99% |
| FY2021 | 531.4K | +1360% |
| FY2020 | 36.4K | −52% |
| FY2019 | 75.2K | +264% |
| FY2018 | 20.7K | +69% |
| FY2017 | 12.2K | +0% |
| FY2016 | 12.2K | +31% |
| FY2015 | 9.3K | +14% |
| FY2014 | 8.2K | +39% |
| FY2013 | 5.9K | +35% |
| FY2012 | 4.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 15.2M | +300% | |
| Q1 FY26 | 10.9M | +218% | |
| Q4 FY25 | 4.9M | +56% | |
| Q3 FY25 | 4.4M | +124% | |
| Q2 FY25 | 3.8M | +119% | |
| Q1 FY25 | 3.4M | +101% | |
| Q4 FY24 | 3.1M | +110% | |
| Q3 FY24 | 2M | +83% | |
| Q2 FY24 | 1.7M | +60% | |
| Q1 FY24 | 1.7M | +62% | |
| Q4 FY23 | 1.5M | +42% | |
| Q3 FY23 | 1.1M | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tempest Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.